Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients-Reference-Cited by-同舟云学术

Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients

Published:2014-08-26 Issue:9 Volume:66 Page:1302-1309
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Kameda Tomohiro¹,Dobashi Hiroaki¹,Miyatake Nobuyuki¹,Inoo Masayuki²,Onishi Ikuko²,Kurata Noriyuki²,Mitsunaka Hiroki³,Kawakami Kimihiro³,Fukumoto Tetsuya⁴,Susaki Kentaro¹,Izumikawa Miharu¹,Nakashima Shusaku¹,Shimada Hiromi¹,Takeuchi Yohei¹,Haba Reiji¹,Mano Shohei³,Onishi Hiroaki⁴,Imataki Osamu¹,Matsunaga Takuya¹

Affiliation:

1. Kagawa University; Kagawa Japan

2. Utazu Hama Clinic; Kagawa Japan

3. Kagawa Prefectural Central Hospital; Kagawa Japan

4. Takamatsu Red Cross Hospital; Kagawa Japan

Publisher

Wiley

Subject

Rheumatology

Reference19 articles.

1. Perioperative use of methotrexate;Heldmann;Clin Exp Rheumatol,2010

2. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives;Ekstrom;Arthritis Rheum,2003